Status:

RECRUITING

Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures

Lead Sponsor:

Aspero Medical, Inc.

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

Small Bowel Disease

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Demonstrate superiority of the Aspero Medical Ancora-SB balloon Overtube compared to the Olympus ST-SB1 Balloon Overtube.

Detailed Description

The study objective, demonstrate superiority of the Aspero Ancora-SB balloon overtube compared to the Olympus ST-SB1 Balloon Overtube, is necessary for adoption by clinicians. Broad adoption is expect...

Eligibility Criteria

Inclusion

  • Willing and able to provide informed consent;
  • Subject meets the minimal safety criteria for single balloon enteroscopy: ASA Class I, II, or III;11
  • ≥ 18 years of age to ≤ 90 years of age;
  • Video capsule endoscopy identified lesions in the middle third of the small bowel;
  • Willing and able to comply with all study procedures and follow-up.

Exclusion

  • History of gastric bypass or related procedures;
  • History of foregut and/or midgut surgery;
  • Pathology identified by video capsule is in the proximal 1/3 of the bowel;
  • Pathology identified by video capsule is in the distal 1/3 of the bowel;
  • Anticoagulant and antiplatelet therapy that cannot be stopped for the enteroscopy;
  • Capsule endoscopy did not show clear visualization of pathology in the middle small bowel;
  • Inability to tolerate the investigator's method of sedation that is the standard of care;
  • Any previous small bowel surgery, or anastomosis, that caused extensive adhesions and/or altered anatomy;
  • Allergy to any medications or product used in the endoscopic procedure where the severe allergic reaction cannot be prevented with pre-medication;
  • Pregnancy;
  • Life expectancy \< six (6) months.

Key Trial Info

Start Date :

January 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 15 2025

Estimated Enrollment :

123 Patients enrolled

Trial Details

Trial ID

NCT06111131

Start Date

January 15 2024

End Date

May 15 2025

Last Update

April 19 2024

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Cedars Sinai

Los Angeles, California, United States, 90048

2

University of Maryland

Baltimore, Maryland, United States, 21201

3

Johns Hopkins

Baltimore, Maryland, United States, 21205

4

Washington University School of Medicine in St. Louis

St Louis, Missouri, United States, 63110